High grade lymphoma, Non-Hodgkin lymphoma (NHL)
Results
Phase 2/3
This trial looked at lenalidomide for diffuse large B cell lymphoma that has continued to grow during treatment, or come back after treatment.
Recruitment start: 2 September 2010
Recruitment end: 1 February 2013
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Prof David Cunningham
Celgene Corporation
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Last reviewed: 11 Feb 2020
CRUK internal database number: 7734
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
